Home NDC 71349-999 YCANTH
Product NDC 71349-999
11-digit product format 713490999
Labeler code 71349
Product ID 71349-999_74b0c983-fd38-49b0-a9a6-cb4e7dd777b5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cantharidin
Dosage form SOLUTION
Route TOPICAL
Labeler Verrica Pharmaceuticals Inc.
Application NDA212905
Marketing category NDA
Marketing start 2023-07-21
Substance CANTHARIDIN
Active strength 3.2 mg/.45mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212905-001 YCANTH CANTHARIDIN 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 N212905-001 12233042 2038-08-22 U-3663 Drug product 2025-03-26 N212905-001 12290651 2041-02-19 Drug product 2025-05-16
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N212905-001 NCE 2028-07-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N212905-001 YCANTH 0.7% SOLUTION / TOPICAL RLD, RS 2023-07-21 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 100 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212905-001 12233042 2038-08-22 U-3663 Drug product 2025-03-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212905-001 12290651 2041-02-19 Drug product 2025-05-16 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212905-001 12233042 2038-08-22 U-3663 Drug product 2025-03-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212905-001 12290651 2041-02-19 Drug product 2025-05-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212905-001 12233042 2038-08-22 U-3663 Drug product 2025-03-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212905-001 12290651 2041-02-19 Drug product 2025-05-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212905-001 12233042 2038-08-22 U-3663 Drug product 2025-03-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212905-001 12290651 2041-02-19 Drug product 2025-05-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212905-001 12233042 2038-08-22 U-3663 Drug product 2025-03-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212905-001 12290651 2041-02-19 Drug product 2025-05-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212905-001 11147790 2038-08-22 U-3663 Drug product 2023-08-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212905-001 11147790 2038-08-22 U-3664 Drug product 2023-08-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212905-001 11052064 2035-05-28 U-3665 Drug product 2023-08-15 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212905-001 11052064 2035-05-28 U-3663 Drug product 2023-08-15 03ed91905a0d…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base YCANTH
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CANTHARIDIN 3.2 mg/.45mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination IGL471WQ8P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 244521 Internal RxNorm lookup 2643442 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71349-999 YCANTH (CANTHARIDIN) SOLUTION [VERRICA PHARMACEUTICALS INC.] 4 Current NDC 20241128_7c9bdeaa-9822-4c69-a719-ea4a8643f59c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 71349-999-01 71349099901 1 APPLICATOR in 1 PACKAGE (71349-999-01) / 1 AMPULE in 1 APPLICATOR / .45 mL in 1 AMPULE 1 applicator 2023-07-21 Yes No Current 71349-999-06 71349099906 6 PACKAGE in 1 CARTON (71349-999-06) / 1 APPLICATOR in 1 PACKAGE (71349-999-01) / 1 AMPULE in 1 APPLICATOR / .45 mL in 1 AMPULE 6 package 2023-07-21 Yes No Current